Wednesday, January 18, 2017 10:13:53 AM
1. Comprised of numerous cannabis companies including AXIM Biotech.
2. MJNA has already hit ~50 cents in 2013 and in 2014. (Float & O/S weren't "low" then either.)
3. Some of MJNA's CBD competitors are over $1.00 in their PPSs.
4. MJNA is located in California (world's 6th largest economy) where rec. MJ just became legal.
5. MJNA is poised and well-positioned to enter legal MJ market.
6. High exposure to Wall Street investors via 2 recent Forbes write ups.
7. Lot of U.S. and foreign media coverage on MJNA and it's products in 2016.
8. Highly effective MJNA CBD products used for medical illnesses in USA and over 40 countries.
9. MJNA's HempMeds product is "prescribed" as a medical drug in several countries.
10. New VP of Ops "grew sales to $50 million" in 5 years where he worked previously.
11. CNBC's Steve Grasso and his firm are LONG on MJNA.
12. Potential for big well-known Wall Street AND foreign investors to invest in MJNA.
IN MY OPINION
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM